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Case Report
Ecthyma Gangrenosum and Panniculitis Secondary to
Acute Pseudomonas Myositis Without Bacteremia
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Introduction

Ecthyma gangrenosum (EG) is a relatively uncommon cutaneous manifestation of an underlying Pseudomonas aeruginosa infection and is clinically described as necrotic with gangrenous ulcers surrounded by erythematous halos. Cases of EG may occur in the absence of
bacteremia and have been increasingly reported in literature. Here we present a patient with
features of both EG and panniculitis, despite the lack of underlying bacteremia.

Education
6000 49th St N.
St. Petersburg, FL 33709
(heather.gosnell1@gmail.
com)

Clinical Findings

A 57-year-old male presented to the emergency department with unrelenting right-sided
lower back pain and an “itchy and painful” rash of four to five day duration. The patient had
an extensive history of intravenous drug abuse and had been hospitalized multiple times for
Pseudomonas bacteremia. Upon examination, there were diffuse, erythematous subcutaneous nodules and several individual necrotic ulcerations on the abdomen, upper and lower
extremities, surrounded by erythematous halos. An MRI revealed myositis and edema in the
right paraspinal region, and blood cultures were negative for Pseudomonas.

Discussion

EG is typically classified as bacteremic or non-bacteremic in nature, and there are limited
reports of panniculitis in the absence of bacteremia. This patient’s presentation was unusual
for the diffuse presentation of non-bacteremic EG with panniculitis. Due to the patient’s
past medical history of deep-seeded Pseudomonas infections, bacteria could have been
directly inoculated into the skin at various injection sites.

Conclusion

While EG is an uncommon but well-recognized dermatologic feature of Pseudomonas bacteremia, panniculitis is reportedly less commonly and likely underrecognized. Physicians should
become aware of the cutaneous manifestations of underlying Pseudomonas infection so
appropriate antibiotic therapy can be initiated.

Keywords

ecthyma gangrenosum; Pseudomonas aeruginosa; bacterial infections and mycoses; intravenous substance abuse; panniculitis; myositis

Introduction

Ecthyma gangrenosum (EG) is a relatively uncommon cutaneous manifestation of an underlying Pseudomonas aeruginosa infection and is
clinically described as necrotic with gangrenous
ulcers surrounded by erythematous halos.1 EG
is most often diagnosed in immunocompromised patients with bacteremia.2 Cases of EG
may occur in the absence of bacteremia and

have been increasingly reported in the literature.3-5 Furthermore, there have been various
reports of subcutaneous nodules and panniculitis associated with Pseudomonas infections, with and without septicemia.6-8 Here we
present a patient with features of both EG and
panniculitis, despite a lack of underlying bacteremia.
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Case Presentation

A 57-year-old male presented to the emergency
department with intractable right-sided lower
back pain for five days and an “itchy and painful” rash for four days. He reported the pain
was localized to his right lower back and did
not radiate. The pain worsened with walking
and movement, and it improved with rest. The
patient reported the rash appeared one day
after the back pain began. He could not identify
where the rash began or how it had spread, but
he said that lesions were present on his chest,
abdomen, dorsal and ventral surfaces of the
forearms and shins, and the backs of his hands.
This patient had an extensive past medical history of IV drug abuse and recurrent pansensitive Pseudomonas aeruginosa bacteremia with
various complications and untreated hepatitis
B and C. He was hospitalized on multiple occasions for treatment with IV antibiotics three
and four months prior due to Pseudomonas
bacteremia with septic arthritis and cervical
discitis with a prevertebral abscess. At that
time, he completed a six-week course of IV
ciprofloxacin and cefepime before discharge.
He was not able to follow-up as an outpatient
due to a lack of insurance and non-adherence.
Eleven months prior to this admission, he was
hospitalized for lumbar osteomyelitis secondary to Pseudomonas bacteremia and was treated with meropenem.
A physical exam revealed exquisite tenderness
to the right paraspinal region. On the trunk, upper and lower extremities, there were diffuse,
erythematous subcutaneous nodules and several individual necrotic ulcerations surrounded
by erythematous halos, measuring between 0.5
cm and 2 cm in size. In the emergency department, vital signs were stable. There was mild
leukopenia at 4.17 x 103/uL, neutrophil count
at 69.1% and immature granulocyte count at
0.70%. At that time, absolute neutrophil count
(ANC) was within normal limits at 2.88 x 103/
uL. The patient was found to have an elevated ESR at 20 mm/hr and CRP at 2.78 mg/dL.
Blood cultures were collected in the emergency
department prior to treatment. An MRI of the
lumbar spine revealed muscle edema and myositis extending from T11 to the sacrum within
the erector spinae muscle.
The patient was presumably diagnosed with
ecthyma gangrenosum secondary to suspected
346

pseudomonal myositis. Empiric treatment with
IV vancomycin and ciprofloxacin was started for
broad-spectrum coverage while blood cultures
were pending. Patient was provided limited
pain medication due to his history of narcotic
abuse. Blood cultures were positive only for
Staphylococcus epidermidis and Staphylococcus
hominis in one of four vials and were thought
to be a contaminant from the skin flora.
On the second and third day of admission, the
patient’s white blood cell count continued to
downtrend to 2.46 and 1.50 x 103/uL respectively. The absolute neutrophil count decreased to
0.92 x 103/uL, reflective of neutropenia. It was
suspected the transient leukopenia was secondary to bone marrow suppression from the
vancomycin and ciprofloxacin. Infectious disease was consulted and recommended discontinuation of the vancomycin and ciprofloxacin.
The patient was started on a two-week course
of IV cefepime. His white blood cell count slowly increased over the next few days of admission. The patient reported daily improvement
in his back pain throughout the course of his
stay. With continued antibiotic treatment over
the next two weeks, the myositis and neutropenia continued to improve, and the nodules
and ulcers slowly resolved without evidence of
scarring.
Upon discharge, he was provided with a twoweek course of ciprofloxacin. The patient was
counseled on the importance of completing
the course of antibiotics and was in agreement
with the treatment plan. Case management
provided him with information on local free
health clinics for follow-up appointments to aid
in treatment adherence.

Discussion

Two types of EG have been described in the literature: bacteremic or nonbacteremic EG. Bacteremic or classic EG is due to a hematogenous
spread of bacteria with positive blood cultures.
Nonbacteremic or localized EG is secondary to
direct inoculation with negative blood cultures.
Patients with the nonbacteremic form tend to
have a better prognosis than those with bacteremia, but secondary bacteremia may occur in
the setting of delayed treatment.9
While Pseudomonas is the most common
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culprit behind EG lesions in up to 74% of cases,10 many other organisms have been found
to produce EG-like lesions in septic states.
Bacterial causes include methicillin-resistant
Staphylococcus aureus (MRSA), Streptococcus
pyogenes, Citrobacter freundii, Escherichia coli,
Aeromonas hydrophila, Serratia marcescens,
Klebsiella pneumoniae, Corynebacterium diphtheriae, Neisseria gonorrhea, Yersinia pestis and
Proteus mirabilius.9-13 One study found 9% of
EG cases are fungal in origin,10 and additional
case reports have identified Candida,14 Mucor,15
Aspergillus and other species in such lesions.
EG tends to occur in the setting of an underlying immunodeficiency such as neutropenia,
HIV/AIDS, leukemias or in patients undergoing
systemic chemotherapy or immunosuppression.16, 17 However, it can infrequently occur in
those who are immunocompetent and previously healthy.10 Overall, it is rare to observe EG
secondary to Pseudomonas in the absence of
bacteremia.
Lesions in EG typically begin as painless, round
erythematous macules that subsequently
indurate and progress to hemorrhagic bullae.
Perivascular invasion and production of virulence enzymes like exotoxin A, elastase and
phospholipase C subsequently leads to surrounding ischemic necrosis and formation of
the necrotic ulcer.16, 18 Lesions are most often
seen in the groin, axillary and perianal areas but
can be seen in other areas,10 as demonstrated
by this patient. While the lesions do not initially
present as ulcers, the delayed presentation of
this patient demonstrated the downstream
manifestations of EG and raised clinical suspicion of an underlying Pseudomonas infection.
Panniculitis also typically presents in patients
with underlying septicemia and immunosuppression.19 However, to our knowledge, very
limited literature exists on panniculitis in the
context of Pseudomonas infection without
bacteremia.6-8 One study found that in cases of
panniculitis without septicemia, all patients had
local skin injuries, and Pseudomonas could be
cultured from half of the patients’ lesions. This
outcome may suggest long-term wound colonization favors skin infection,8 which is consistent
with this patient’s presentation and infection
history.

In this patient, the lesions were not localized,
and the EG was presumed to be the nonbacteremic type based on the results of the
blood culture, though an unusual presentation. Due to the patient’s past medical history
of deep-seeded Pseudomonas infections, it
is possible bacteria could have been directly
introduced into the skin at various injection
sites and potentially achieved local spread via
the lymphatics, as proposed in previous case
reports.6, 8

Conclusion

While EG is an uncommon but well-recognized
dermatologic feature of Pseudomonas bacteremia, panniculitis is reportedly less common
and likely underrecognized. Both of these skin
conditions typically present in the context of
immunosuppression and bacteremia, which
were notably absent in this patient. This case
exemplifies the importance of a thorough
physical exam in critically ill patients who present with skin lesions and have a recent history
of bacteremia. Physicians should be aware
of the various cutaneous manifestations of
underlying Pseudomonas infections, especially
when the patient lacks the classic signs of sepsis and bacteremia, such that antibiotic therapy may be initiated as quickly as possible.
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